Navigation Links
Cantel Medical Corp. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference
Date:10/29/2008

LITTLE FALLS, N.J., Oct. 29 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President, will be presenting at the Oppenheimer & Co. Inc. 19th Annual Healthcare Conference. The presentation is scheduled for 10:00 AM ET on Monday, November 3, 2008 at the Waldorf-Astoria in New York City. The presentation will be available on the Investor Relations section of the company's website: http://www.cantelmedical.com.

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cantel Medical to Relocate Dutch Manufacturing Operations to the United States to Achieve Operating Savings
2. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
3. Lazarex Cancer Foundation Sponsors Community Colorectal Cancer Screening at Alta Bates Summit Medical Center
4. China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference
5. ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call
6. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
7. China Sky One Medical, Inc. Acquires Drug to Treat Breast Lesions
8. Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
9. Medical Reimbursement Consultants, Inc. Selects LeonardoMD for Web-based Medical Billing
10. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
11. Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... 10, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... other healthcare organizations to promote diabetes education at the World Diabetes Day observance. ... of speakers from around the Commonwealth of Pennsylvania. Speakers included Dr. Renu ...
(Date:12/9/2016)... ... December 09, 2016 , ... The American ... audiologists—to remain a critical part of public access to hearing aid technology. , ... announced this week that, starting immediately, it would no longer enforce the ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... folded, pharmaceutical inserts and outserts. As a means of expanding capabilities Flottman ... will enable Flottman to individually code professional inserts (PIs) and patient package inserts ...
(Date:12/9/2016)... Woodland Hills, CA (PRWEB) , ... December 09, ... ... center for young adults, celebrated its 10th anniversary with the grand opening of ... Hills, California. The successful event spanned two days, December 2-3, and was attended ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Hotel in New York, NY, on December 3rd, to benefit Holy Name Medical ... the annual event, which raised over $1 million - the largest event in ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... grow in 2017-2023. Various reasons for growth of the ... higher incidences of chronic diseases, high recovery cost of ... services. Medical lifting sling refers to an assistive ... mobility. These slings connect to the lift and hold ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
Breaking Medicine Technology: